PD-1 blockade therapy enhances the antitumor effects of lymphodepletion and adoptive T cell transfer

被引:0
|
作者
Watanabe, Satoshi
Takahashi, Miho
Suzuki, Ryo
Arita, Masashi
Sato, Ko
Fujisaki, Toshiya
Ohtsubo, Aya
Shoji, Satoshi
Shono, Kunihiro
Masuda, Takaaki
Sekiya, Tomoki
Nozaki, Koichiro
Tanaka, Tomohiro
Kondo, Rie
Saida, Yu
Hokari, Satoshi
Koya, Toshiyuki
Kikuchi, Toshiaki
机构
关键词
D O I
10.1158/1538-7445.AM2023-4064
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4064
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Antitumor activity of dual PD-1 and LAG-3 blockade reversed by adoptive transfer of tumor-draining lymph node cells
    Liang, Wei
    Valdovinos, Lilibet
    Yapjoco, Kaitlyn
    Hinata, Kaede
    Sharma, Geeta
    Broudy, Thomas B.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [42] ALL Progression Induces PD1 on T Cells and Blockade of PD1 Enhances Adoptive Immunotherapy
    Burk, Chad R.
    Fix, William
    Qin, Haiying
    Fry, Terry J.
    BLOOD, 2011, 118 (21) : 1110 - 1111
  • [43] Immunostimulatory gene therapy enhances PD-1 blockade antibody therapy in experimental lung cancer
    Wenthe, Jessica
    Eriksson, Emma
    Hellstrom, Ann-Charlotte
    Loskog, Angelica
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (09)
  • [44] Effective adoptive T-cell therapy for cancer in the absence of host lymphodepletion
    Gilham, David E.
    IMMUNOTHERAPY, 2011, 3 (02) : 177 - 179
  • [45] Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy
    Hussein A. Abbas
    Dapeng Hao
    Katarzyna Tomczak
    Praveen Barrodia
    Jin Seon Im
    Patrick K. Reville
    Zoe Alaniz
    Wei Wang
    Ruiping Wang
    Feng Wang
    Gheath Al-Atrash
    Koichi Takahashi
    Jing Ning
    Maomao Ding
    Hannah C. Beird
    Jairo T. Mathews
    Latasha Little
    Jianhua Zhang
    Sreyashi Basu
    Marina Konopleva
    Mario L. Marques-Piubelli
    Luisa M. Solis
    Edwin Roger Parra
    Wei Lu
    Auriole Tamegnon
    Guillermo Garcia-Manero
    Michael R. Green
    Padmanee Sharma
    James P. Allison
    Steven M. Kornblau
    Kunal Rai
    Linghua Wang
    Naval Daver
    Andrew Futreal
    Nature Communications, 12
  • [46] Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy
    Abbas, Hussein A.
    Hao, Dapeng
    Tomczak, Katarzyna
    Barrodia, Praveen
    Im, Jin Seon
    Reville, Patrick K.
    Alaniz, Zoe
    Wang, Wei
    Wang, Ruiping
    Wang, Feng
    Al-Atrash, Gheath
    Takahashi, Koichi
    Ning, Jing
    Ding, Maomao
    Beird, Hannah C.
    Mathews, Jairo T.
    Little, Latasha
    Zhang, Jianhua
    Basu, Sreyashi
    Konopleva, Marina
    Marques-Piubelli, Mario L.
    Solis, Luisa M.
    Parra, Edwin Roger
    Lu, Wei
    Tamegnon, Auriole
    Garcia-Manero, Guillermo
    Green, Michael R.
    Sharma, Padmanee
    Allison, James P.
    Kornblau, Steven M.
    Rai, Kunal
    Wang, Linghua
    Daver, Naval
    Futreal, Andrew
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [47] PD-1 Signaling Has a Critical Role in Maintaining Regulatory T Cell Homeostasis; Implication for Treg Depletion Therapy By PD-1 Blockade
    Asano, Takeru
    Kishi, Yuriko
    Meguri, Yusuke
    Yoshioka, Takanori
    Iwamoto, Miki
    Maeda, Yoshinobu
    Yagita, Hideo
    Tanimoto, Mitsune
    Koreth, John
    Ritz, Jerome
    Matsuoka, Ken-Ichi
    BLOOD, 2015, 126 (23)
  • [48] PD-1 checkpoint blockade therapy enhances adoptive immunotherapy by human Vγ2Vδ2 T cells against prostate tumors in a preclinical model
    Nada, Mohanad H.
    Wang, Hong
    Morita, Craig
    CANCER RESEARCH, 2018, 78 (13)
  • [49] Taurine enhances the antitumor efficacy of PD-1 antibody by boosting CD8+ T cell function
    Ping, Yu
    Shan, Jiqi
    Liu, Yaqing
    Liu, Fengsen
    Wang, Liuya
    Liu, Zhangnan
    Li, Jieyao
    Yue, Dongli
    Wang, Liping
    Chen, Xinfeng
    Zhang, Yi
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (04) : 1015 - 1027
  • [50] Taurine enhances the antitumor efficacy of PD-1 antibody by boosting CD8+ T cell function
    Yu Ping
    Jiqi Shan
    Yaqing Liu
    Fengsen Liu
    Liuya Wang
    Zhangnan Liu
    Jieyao Li
    Dongli Yue
    Liping Wang
    Xinfeng Chen
    Yi Zhang
    Cancer Immunology, Immunotherapy, 2023, 72 : 1015 - 1027